Celcuity, Inc. (CELC)
104.50
-3.01
(-2.80%)
USD |
NASDAQ |
Jan 12, 16:00
104.50
0.00 (0.00%)
After-Hours: 17:25
Celcuity Research and Development Expense (Quarterly): 34.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Olema Pharmaceuticals, Inc. | 39.95M |
| Replimune Group, Inc. | 57.65M |
| Arrowhead Pharmaceuticals, Inc. | 168.80M |
| Cidara Therapeutics, Inc. | 35.53M |
| Cogent Biosciences, Inc. | 67.84M |